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To determine if the movement proteins (MPs) of cucumber mosaic cucumovirus (CMV) and tobacco mosaic tobamovirus
(TMV) are complementary in function, transgenic plants expressing genes encoding TMV or CMV MP were inoculated with
movement-defective mutants of TMV and CMV. Transgenic plants expressing the MP gene of CMV strain S (subgroup II)
complemented the cell-to-cell and systemic spread of a movement-defective mutant of CMV strain Fny (subgroup I) but not
the local or systemic spread of a movement-defective mutant of TMV. Plants that contained the MP gene from CMV-S were
not resistant to wild-type TMV infection. When inoculated with a movement-defective mutant of TMV that produced b-
glucuronidase, transgenic plants with the CMV MP gene supported only subliminal infection. Conversely, immunodetection
and in situ localization techniques revealed that transgenic plants accumulating the TMV MP supported cell-to-cell spread,
but not systemic transport, of a movement-defective CMV. These studies suggest that the transgenic TMV MP shares some
of the functions with the CMV MP required to transport CMV, whereas the transgenic CMV MP is deficient in functions
that are needed to mobilize the spread of TMV infection. q 1996 Academic Press, Inc.
Following infection, a plant virus can move into neigh- movement, whereas TMV does not (13, 14). To examine
the roles of the TMV and CMV MPs in complementingboring cells, a process potentiated by the viral-encoded
movement protein (MP; 1). When a virus does not move heterologous viral movement in a common host, we inoc-
ulated transgenic plants expressing TMV or CMV MPand is restricted to the initially inoculated cells, the infec-
tion is subliminal (2). Certain plant viruses can facilitate genes with movement-defective CMV and TMV.
The CMV strain S (subgroup II; 15) MP gene was ampli-the spread of a second plant virus which, by itself, is
limited to subliminal infection in a particular host (3, 4). fied by PCR from a partial cDNA clone of RNA 3 of CMV-
S (pS19IIH4; G. Rodriguez and J. A. Dodds, unpublishedThis phenomenon can result when one MP provides a
function in lieu of, or in conjunction with, the dysfunc- data), sequenced (Silver Sequencing, Promega), cloned
into pMON316 in forward and reverse directions, andtional MP (5– 7). Such complementation can occur for
viruses within and between taxonomic groups (8 – 10). used for transformation of Nicotiana tabacum cv. Xanthi
NN (16). Transgenic plants of lines BFNNC, BFNNH,These observations and others reveal that MPs, while
sharing few amino acid sequence similarities (11), can BFNNL, BFNNQ (MP gene in sense orientation), and
BRNNO (MP gene in antisense orientation) wereexhibit complementary functions.
Cucumber mosaic virus (CMV) is a tripartite icosahe- screened for the presence of nopaline (17). The presence
of the CMV MP transgene was determined by amplifyingdral virus and is the type member of the cucumovirus
group, whereas tobacco mosaic virus (TMV) is the type the CMV-S MP gene from plant genomic DNA using PCR.
Antiserum to determine the levels of MP accumulationmember of the monopartite, rod-shaped tobamoviruses.
Both viruses encode a single MP that potentiates the in the plants was not available for this study. Plants
shown to accumulate nopaline (nop/) and to possesscell-to-cell movement of the respective viruses (8, 12),
and both viruses can systemically infect tobacco. CMV the CMV MP gene were allowed to self-fertilize, and the
R1 progeny were used in subsequent experiments.requires the coat protein (CP) for efficient cell-to-cell
CMV strains are divided into at least two different sub-
groups based on the antigenic relatedness and se-
The CMV-S MP nucleotide sequence data reported in this article
quence similarities of their capsid proteins and on nu-have been deposited with the GenBank Database under Accession
cleic acid hybridization analysis (18). Direct sequenceNo. U37227.
1 To whom reprint requests should be addressed. comparisons show that the MPs of subgroup II strains
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FIG. 1. Amino acid sequence alignment between (A) CMV strains Q (subgroup II), S (subgroup II), and Fny (subgroup I) movement proteins and
(B) CMV-S and TMV-U1 movement proteins. Identical amino acids are contained in boxes. An uppercase letter that differs from the CMV-S amino
acid in that position denotes an amino acid that is similar but not identical. Lowercase letters represent amino acids that diverge from the CMV-
S amino acid. Hyphens are gaps in sequence that are a result of alignment with FASTA.
TABLE 1
Number of Infection Sites and Number of Cells (Blue) Accumulating GUS per Site on 2005, BFNNL,
and Xanthi NN Plants Inoculated with TMVDMP-GUS
Number of blue cells per site
1 2 –10 11 –30 31 –100 100
Plant lines Number of infection sites for each categorya
2005 (TMV MP/) 1 (1) 5 (7) 17b (23) 16b (22) 35b (47)
Xanthi NN (MP0) 42 (69) 10 (16) 9 (15) 0 0
BFNNL (CMV MP/) 94 (51) 58 (32) 31 (17) 0 0
a Total number of infection sites compounded from one experiment performed on 2005 and Xanthi NN plants and from three experiments performed
on BFNNL plants. Numbers in parentheses are percentage of total number of infection sites on each line.
b Infection sites are associated with local lesions. Unmarked sites are not associated with local lesions.
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FIG. 2. Visualization of (A –E) TMVDMP-GUS and (F– J) CMVFnyDMP-DKPN in nontransgenic and transgenic TMV MP and CMV MP plants. (A)
A single blue cell infected with TMVDMP-GUS on an inoculated leaf of a nontransgenic plant 7 dai (bar, 310 mm). (B) A cluster of 2 –10 cells (left)
and a cluster of 11 – 30 cells (right) infected with TMVDMP-GUS on an inoculated leaf of a nontransgenic plant 7 dai (bar, 310 mm). (C) A cluster
of 100 cells associated with a local lesion on a 2005 plant infected with TMVDMP-GUS 7 dai (bar, 310 mm). (D) Two independently infected
single blue cells (center), a cluster of 11 – 30 cells (far left), and a cluster of 2 –10 cells (far right) on a leaf of a BFNNL plant 7 dai with TMVDMP-
GUS (bar, 240 mm). (E) A comparison between TMVDMP-GUS infection sites on a BFNNL plant (left) and a 2005 plant (right) (bar, 940 mm). (F)
Ringspot-like symptoms induced by CMVFnyDMP-DKPN on the inoculated leaf of a 2005 plant 14 dai. (G) Detection of CMVFnyDMP-DKPN spread
on an inoculated BFNNL leaf 7 dai followed by hybridization with a fluorescein-labeled oligonucleotide specific for CMV-Fny RNA (arrows point to
damaged cells as in H; bar, 90 mm). (H) Mock-inoculated nontransgenic plant which was then probed as in G. Auto-fluorescence of veins and
damaged cellular areas are apparent (arrows point to damaged cells; bar, 70 mm). (I) Subliminal infections of CMVFnyDMP-DKPN on an inoculated
leaf of a nontransgenic plant 7 dai which was then probed as in G (bar, 70 mm). (J) Detection of CMVFnyDMP-DKPN spread on an inoculated 2005
leaf 7 dai which was then probed as in G (arrow points to damaged cells as in H; bar, 70 mm).
/ m4950$7685 01-16-96 14:33:40 viras AP-Virology
211SHORT COMMUNICATION
S and Q share a 98.6% identity and 100% similarity at the stead of the MP gene (21). Leaves were dusted with
Carborundum and rubbed 25 times with inoculum. Leafamino acid level (Fig. 1A). The MP of CMV-S and the MP
of subgroup I CMV-Fny share an 85% identity and a 94.6% discs from the inoculated leaves were collected 7 dai
and were assayed for GUS activity by microscopy (21).similarity (Fig. 1A).
Transgenic plants of lines BFNNC, BFNNH, BFNNL, Of the infection sites examined on inoculated leaves of
nontransformed Xanthi NN plants, 69% were observedBFNNQ, BRNNO, and nontransgenic Xanthi NN plants
were mechanically inoculated with extract prepared from as single, epidermal cells with blue pigment (Table 1;
Fig. 2A). The remaining 31% were clusters of less thandried leaves containing CMVFnyDMP-DKPN, a move-
ment-defective mutant of CMV strain Fny (subgroup I; 30 blue epidermal and mesophyll cells (Fig. 2B). Because
mesophyll cells can be susceptible to direct inoculation19). By 30 days after inoculation (dai), only BFNN series
plants which were nop/ showed strong, vein-clearing (22, 23), it is likely that the multicellular sites containing
GUS (as in Fig. 2B) reflect virus replication in mesophyllsymptoms in systemically infected leaves. Systemic in-
fection was presumed to be the result of CMV MP accu- cells that were multiply inoculated after epidermal cells
were destroyed by the rigorous inoculation procedure.mulation. Extracts from symptomatic leaves lacked infec-
tivity when back-inoculated onto Chenopodium amaranti- However, inoculation stress may have induced physio-
logical responses that enabled the limited movement ofcolor. None of the nontransformed Xanthi NN plants,
nop0 BFNN series plants, or BRNNO plants developed TMV or GUS through local plasmodesmata. We interpret
our data to indicate subliminal infection of movement-symptoms. These results demonstrated that MPs of the
two subgroups were sufficiently similar to enable the defective TMV on nontransgenic plants.
On 2005 plants, local lesions appeared at the sites oftransgenic plants expressing the CMV-S MP gene to
complement the spread of movement-defective infection and were accompanied by large numbers of
cells that accumulated GUS. Of the number of sites ofCMVFnyDMP-DKPN.
The MPs of TMV and CMV-S exhibit only a 12.8% iden- infection examined, 47% contained greater than 100 in-
fected cells (Fig. 2C), and 22% comprised less than 100tity and a 62% similarity based on FASTA (Fig. 1B). To
determine if CMV MP can complement movement-defec- cells but more than 30 cells (Table 1). A limited number
of infections (8%) had not induced local lesions at thetive TMV, we inoculated nop/ BFNN series plants, 2005
plants, and negative controls with extracts containing time of sampling (Table 1). When nop/ BFNNL plants
were inoculated with TMVDMP-GUS, a majority of theTMVDMP-RV, a movement-defective mutant of TMV that
induces local lesions on 2005 plants [transgenic N. taba- infection sites were subliminal and similar to those de-
tected on nontransformed Xanthi NN plants (Table 1; Fig.cum cv. Xanthi NN line 2005 accumulates TMV MP (8)]
but will cause only subliminal infections on nontrans- 2D). None of the infection sites expressing GUS on the
BFNNL plants was associated with local lesions. Failureformed Xanthi NN plants (20). No lesions appeared on
any of the BFNN series or nontransgenic plants by 12 dai, of CMV-S MP to support the spread of movement-defec-
tive TMV agrees with a previous, similar observation (19).whereas 2005 plants developed TMV-induced lesions at
4 dai. To determine if symptomless, systemic infections While the data presented above confirmed that the
CMV MP does not complement the cell-to-cell transporthad occurred, extracts from the symptomless upper
leaves of these plants were back-inoculated onto 2005 of a movement-defective TMV, we envisioned that the
TMV MP would complement the transport of a move-plants. No lesions appeared on 2005 plants by 6 dai,
indicating that TMVDMP-RV had not moved systemically ment-defective CMV because CMV infections develop
more rapidly in plants that accumulate functional TMVin any of the BFNN series plants.
Because there was no induction of local lesions on MP than in nontransgenic plants (7). To examine the
possibility, we inoculated 2005, BFNNL, and nontrans-BFNN line plants by TMVDMP-RV we considered the
possibility that the CMV MP conferred resistance to TMV. formed Xanthi NN plants with CMVFnyDMP-DKPN. By
14 dai, vein-clearing symptoms appeared on the sys-Plants were inoculated with wild-type TMV, and local
lesions were counted. Lesions formed on all BFNN se- temic leaves of nop/ BFNNL plants while the nontrans-
formed plants remained symptomless. Necrotic ringspot-ries nop/ plants, indicating that TMV infection occurred.
There were no significant differences between the size like symptoms developed on the inoculated leaves of
2005 plants at 14 dai (Fig. 2F) while the upper leavesand number of lesions formed on the BFNN series and
nontransformed plants (data not shown), indicating that remained symptomless. Immunoblot analysis for CP (7)
in extracts prepared at 7 dai from the inoculated leavesthe CMV-S MP did not inhibit the infection of TMV.
To determine if the CMV MP supports the local spread of 2005 plants revealed the presence of CMVFnyDMP-
DKPN at 38% of the amount detected in BFNNL plantsof movement-defective TMV without inducing local le-
sions, we inoculated plants of lines BFNNL, 2005, and (data not shown). This indicated that the TMV MP sup-
ports the movement of CMVFnyDMP-DKPN in the inocu-Xanthi NN with TMVDMP-GUS, a movement-defective
TMV that expresses the b-glucuronidase (GUS) gene in- lated leaf, but less efficiently than CMV MP. We could
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not detect CMVFnyDMP-DKPN coat protein in the upper DKPN does not move systemically in 2005 plants. In
contrast, CMV MP lacks the capacity to function for TMV.leaves of 2005 plants at 14 dai.
To confirm that the TMV MP assisted the local Although the CMV and TMV MPs are each known to
modify the size-exclusion limits of plasmodesmata (26,spread of CMVFnyDMP-DKPN, leaves of the 2005,
BFNNL, and Xanthi NN plants were inoculated and 12), and each MP can bind nucleic acids (27, 28), other
observations suggest that the MPs have individual and,prepared at 7 dai for in situ hybridization (24) with
a CMV-specific fluorescein-labeled oligonucleotide perhaps, specialized roles (29). This substantiates the
proposal that the CMV MP may not interact with the TMVprobe complementary to the 3* homologous region of
the CMV genomic RNAs. Veins and stomata of mock- genome or support TMV cell-to-cell movement. Further-
more, CMV requires CP for local spread, whereas TMVinoculated plants exhibited auto-fluorescence (Fig.
2H), precluding the quantification of single, infected does not (13, 14). The absence of the CMV CP may be
an important reason for the lack of spread of movement-cells and detection of viral RNA in the veins of
virus-inoculated plants. Mock-inoculated plants also defective TMV in transgenic plants with the CMV MP.
We have yet to identify the functional domains of theshowed auto-fluorescence of damaged tissue that re-
sulted from inoculation and/or processing (Fig. 2H). CMV and TMV MPs that are necessary to facilitate the
heterologous complementation of the two viruses. DoingWhen BFNNL tissue inoculated with CMVFnyDMP-
DKPN was examined, we found large areas of fluores- so should help us deduce characteristics shared by the
MPs and further elucidate how plant viruses move be-cent cells characteristic of cell-to-cell movement (Fig.
2G). It was important to distinguish the fluorescence tween cells.
indicative of viral movement from the auto-fluores-
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